🚀 VC round data is live in beta, check it out!
Treace Medical Concepts Valuation Multiples
Discover revenue and EBITDA valuation multiples for Treace Medical Concepts and similar public comparables like CROSSJECT, Onyx Healthcare, Viromed Medical, Hyperfine and more.
Treace Medical Concepts Overview
About Treace Medical Concepts
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
Founded
2014
HQ
Employees
477
Website
Financials (LTM)
EV
$149M
Treace Medical Concepts Financials
Treace Medical Concepts reported last 12-month revenue of $211M and negative EBITDA of ($4M).
In the same LTM period, Treace Medical Concepts generated $167M in gross profit, ($4M) in EBITDA losses, and had net loss of ($59M).
Revenue (LTM)
Treace Medical Concepts P&L
In the most recent fiscal year, Treace Medical Concepts reported revenue of $213M and EBITDA of ($4M).
Treace Medical Concepts expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $211M | XXX | $213M | XXX | XXX | XXX |
| Gross Profit | $167M | XXX | $170M | XXX | XXX | XXX |
| Gross Margin | 79% | XXX | 80% | XXX | XXX | XXX |
| EBITDA | ($4M) | XXX | ($4M) | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | (2%) | XXX | XXX | XXX |
| EBIT Margin | (26%) | XXX | (25%) | XXX | XXX | XXX |
| Net Profit | ($59M) | XXX | ($59M) | XXX | XXX | XXX |
| Net Margin | (28%) | XXX | (28%) | XXX | XXX | XXX |
| Net Debt | — | — | $47M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Treace Medical Concepts Stock Performance
Treace Medical Concepts has current market cap of $125M, and enterprise value of $149M.
Market Cap Evolution
Treace Medical Concepts' stock price is $1.93.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $149M | $125M | 0.0% | XXX | XXX | XXX | $-0.91 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTreace Medical Concepts Valuation Multiples
Treace Medical Concepts trades at 0.7x EV/Revenue multiple, and (33.9x) EV/EBITDA.
EV / Revenue (LTM)
Treace Medical Concepts Financial Valuation Multiples
As of April 19, 2026, Treace Medical Concepts has market cap of $125M and EV of $149M.
Equity research analysts estimate Treace Medical Concepts' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Treace Medical Concepts has a P/E ratio of (2.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $125M | XXX | $125M | XXX | XXX | XXX |
| EV (current) | $149M | XXX | $149M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | (33.9x) | XXX | (38.1x) | XXX | XXX | XXX |
| EV/EBIT | (2.7x) | XXX | (2.7x) | XXX | XXX | XXX |
| EV/Gross Profit | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| P/E | (2.1x) | XXX | (2.1x) | XXX | XXX | XXX |
| EV/FCF | (6.8x) | XXX | (5.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Treace Medical Concepts Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Treace Medical Concepts Margins & Growth Rates
Treace Medical Concepts' revenue in the last 12 month grew by 0%.
Treace Medical Concepts' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.5M for the same period.
Treace Medical Concepts' rule of 40 is (6%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Treace Medical Concepts' rule of X is (11%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Treace Medical Concepts Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | (2%) | XXX | XXX | XXX |
| EBITDA Growth | 18% | XXX | 42% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (6%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (11%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 66% | XXX | 66% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 30% | XXX | 30% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 105% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Treace Medical Concepts Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Treace Medical Concepts | XXX | XXX | XXX | XXX | XXX | XXX |
| CROSSJECT | XXX | XXX | XXX | XXX | XXX | XXX |
| Onyx Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Viromed Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Hyperfine | XXX | XXX | XXX | XXX | XXX | XXX |
| Edap TMS | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Treace Medical Concepts M&A Activity
Treace Medical Concepts acquired XXX companies to date.
Last acquisition by Treace Medical Concepts was on XXXXXXXX, XXXXX. Treace Medical Concepts acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Treace Medical Concepts
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTreace Medical Concepts Investment Activity
Treace Medical Concepts invested in XXX companies to date.
Treace Medical Concepts made its latest investment on XXXXXXXX, XXXXX. Treace Medical Concepts invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Treace Medical Concepts
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Treace Medical Concepts
| When was Treace Medical Concepts founded? | Treace Medical Concepts was founded in 2014. |
| Where is Treace Medical Concepts headquartered? | Treace Medical Concepts is headquartered in United States. |
| How many employees does Treace Medical Concepts have? | As of today, Treace Medical Concepts has over 477 employees. |
| Who is the CEO of Treace Medical Concepts? | Treace Medical Concepts' CEO is John T. Treace. |
| Is Treace Medical Concepts publicly listed? | Yes, Treace Medical Concepts is a public company listed on Nasdaq. |
| What is the stock symbol of Treace Medical Concepts? | Treace Medical Concepts trades under TMCI ticker. |
| When did Treace Medical Concepts go public? | Treace Medical Concepts went public in 2021. |
| Who are competitors of Treace Medical Concepts? | Treace Medical Concepts main competitors are CROSSJECT, Onyx Healthcare, Viromed Medical, Hyperfine. |
| What is the current market cap of Treace Medical Concepts? | Treace Medical Concepts' current market cap is $125M. |
| What is the current revenue of Treace Medical Concepts? | Treace Medical Concepts' last 12 months revenue is $211M. |
| What is the current revenue growth of Treace Medical Concepts? | Treace Medical Concepts revenue growth (NTM/LTM) is 0%. |
| What is the current EV/Revenue multiple of Treace Medical Concepts? | Current revenue multiple of Treace Medical Concepts is 0.7x. |
| Is Treace Medical Concepts profitable? | No, Treace Medical Concepts is not profitable. |
| What is the current EBITDA of Treace Medical Concepts? | Treace Medical Concepts has negative EBITDA and is not profitable. |
| What is Treace Medical Concepts' EBITDA margin? | Treace Medical Concepts' last 12 months EBITDA margin is (2%). |
| What is the current EV/EBITDA multiple of Treace Medical Concepts? | Current EBITDA multiple of Treace Medical Concepts is (33.9x). |
| What is the current FCF of Treace Medical Concepts? | Treace Medical Concepts' last 12 months FCF is ($22M). |
| What is Treace Medical Concepts' FCF margin? | Treace Medical Concepts' last 12 months FCF margin is (10%). |
| What is the current EV/FCF multiple of Treace Medical Concepts? | Current FCF multiple of Treace Medical Concepts is (6.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.